Consumer trust in pharma industry holds steady amid economic, inequality uneasiness — Edelman survey
Trust in pharma companies notched a small one percent year-over-year gain in Edelman’s annual trust study but against a backdrop of big increases in other consumer health concerns.
Economic anxiety, along with worries about healthcare access and inequality, saw major spikes in the Trust and Health 2023 global study across 13 countries published on Tuesday — with correlating health and pharma industry implications.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
